Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly slight » significantly lighter (Expand Search), significantly high (Expand Search), significantly higher (Expand Search)
slight decrease » slight increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly slight » significantly lighter (Expand Search), significantly high (Expand Search), significantly higher (Expand Search)
slight decrease » slight increase (Expand Search)
-
361
-
362
-
363
Facilities offering modern family planning services by division in 2014 (A) and 2017 (B).
Published 2025Subjects: -
364
-
365
-
366
Modern family planning service readiness score by division in 2014 (A) and 2017 (B).
Published 2025Subjects: -
367
-
368
Mean readiness score of modern family planning service by facility type in 2014 and 2017.
Published 2025Subjects: -
369
Overall and domain-specific mean readiness score by survey years, 2014 and 2017.
Published 2025Subjects: -
370
Percentage distribution (weighted) of surveyed facilities in 2014 and 2017.
Published 2025Subjects: -
371
-
372
-
373
-
374
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
375
-
376
-
377
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
378
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
379
-
380